Horner's SD After Thoracic Epidural Block

NCT02130739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2014-05-05

No results posted yet for this study

Summary

This study prospectively evaluates the incidence of Horner's syndrome after thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy. The incidence was 1.36% and the mechanism of Horner's syndrome was cephalic spread of the local anesthetic.

Conditions

  • Horner's Syndrome

Interventions

PROCEDURE

thoracic epidural anesthesia

thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy

PROCEDURE

mastectomy

mastectomy with/without breast reconstruction

DRUG

Ropivacaine

Thoracic epidural anesthesia performed using 0.375% or 0.5% ropivacaine

DRUG

Propofol

Thoracic epidural anesthesia performed followed by sedation consisting of propofol

DRUG

Fentanyl

thoracic epidural analgesia continued; supplemented by a continuous epidural infusion of ropivacaine 0.15%, 2 ml/h with fentanyl 8mcg/h.

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-12-31
Completion
2014-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02130739 on ClinicalTrials.gov